169 related articles for article (PubMed ID: 4157882)
41. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
Böhnel J; Stacher A
Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
[No Abstract] [Full Text] [Related]
42. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
43. [Treatment of chronic leukemias].
Fiorentino M
Cancro; 1973; 26(5):345-57. PubMed ID: 4526631
[No Abstract] [Full Text] [Related]
44. Midwest cooperative group evaluation of piposulfan (A-20968) in cancer.
Nelson NA; Talley RW; Reed ML; Evans AM; Isaacs BL; Huffman P; Louis J
Clin Pharmacol Ther; 1967; 8(3):385-91. PubMed ID: 5338383
[No Abstract] [Full Text] [Related]
45. [Quantification of granulocyte protection in hemoblastoses].
Senn HJ; Jungi WF
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):337-46. PubMed ID: 4139053
[No Abstract] [Full Text] [Related]
46. [Ambulatory treatment of myelocytic and lymphocytic leukemia].
Volkova MA
Ter Arkh; 1975; 47(6):19-26. PubMed ID: 1059267
[No Abstract] [Full Text] [Related]
47. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
[No Abstract] [Full Text] [Related]
48. [Rubidomycine. A new antineoplastic antibiotic].
Soulié L
Munch Med Wochenschr; 1968 Jun; 110(25):1539-41. PubMed ID: 5252222
[No Abstract] [Full Text] [Related]
49. [Progress in the treatment of acute leukemia: status in 1971].
Jungi WF; Senn HJ
Schweiz Rundsch Med Prax; 1971 Dec; 60(52):1737-46. PubMed ID: 5289956
[No Abstract] [Full Text] [Related]
50. [Chemotherapy of leukemia].
Obrecht P
Internist (Berl); 1968 Dec; 9(12):489-95. PubMed ID: 4891475
[No Abstract] [Full Text] [Related]
51. Trenimon treatment in chronic hemoblastoses.
Quattrin N; Dini E; Montuori R
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):145-52. PubMed ID: 4968994
[No Abstract] [Full Text] [Related]
52. [Large granular lymphocytic leukemia].
Wyszecka-Polk I; Prejzner W
Wiad Lek; 1998; 51(7-8):368-72. PubMed ID: 9748893
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of the effectiveness of the ambulatory treatment of chronic leukemia patients and a determination of their work capacity].
Kovaleva LG; Sivukha TA; Nevskaia TP; Naumova GA; Sevast'ianova MG
Gematol Transfuziol; 1985 Dec; 30(12):3-7. PubMed ID: 3866723
[No Abstract] [Full Text] [Related]
54. [Status of plasma blood clotting factors during different stages of erythromyelosis in rats and the effect of hexaphosphamide on the indices studied].
Stepanian MA; Chilingarian AG; Muradian LB
Zh Eksp Klin Med; 1978; 18(2):24-8. PubMed ID: 278414
[No Abstract] [Full Text] [Related]
55. Therapy of acute leukemia.
Durie BG
Ariz Med; 1974 Apr; 31(4):283-4. PubMed ID: 4524603
[No Abstract] [Full Text] [Related]
56. Treatment of AGL.
Lee SL; Rosner F
Arch Intern Med; 1969 Feb; 123(2):205-6. PubMed ID: 5249563
[No Abstract] [Full Text] [Related]
57. Leukemia and the hypercoagulable state. Pathogenic and therapeutic implications.
Brodsky I
J Med; 1974; 5(1):38-49. PubMed ID: 4524857
[No Abstract] [Full Text] [Related]
58. Evaluation of two antineoplastic agents, PIPOBROMAN (vercyte) and thioguanine.
JAMA; 1967 May; 200(7):619-20. PubMed ID: 5228673
[No Abstract] [Full Text] [Related]
59. [Principles of treatment of hemoblastoses under ambulatory conditions].
Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
[No Abstract] [Full Text] [Related]
60. Phase II trial of diaziquone in advanced renal adenocarcinoma.
Hansen M; Gallmeier WM; Vermorken J; Holdener E; Hansen HH; Renard J; Rozencweig M
Cancer Treat Rep; 1984; 68(7-8):1055-6. PubMed ID: 6744342
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
